Free Trial

Skye Bioscience (SKYE) SEC Filings & 10K Form

Skye Bioscience logo
$1.87 -0.25 (-11.79%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.88 +0.00 (+0.27%)
As of 03/28/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Skye Bioscience SEC Filings

DateFilerForm TypeView
03/20/2025
3:03 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
3:04 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
5:54 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4/A
02/26/2025
6:45 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:53 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:27 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
4:34 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:38 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:41 PM
Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:43 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:45 PM
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:47 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:51 PM
Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:09 PM
5AM Partners VII, LLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form SCHEDULE 13D/A
11/20/2024
7:23 AM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:57 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:14 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:20 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:22 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:25 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:28 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:31 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
9:02 AM
JANUS HENDERSON GROUP PLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form SC 13G/A
11/14/2024
8:21 AM
Altium Capital Management LP (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
Form SC 13G/A
10/30/2024
7:25 PM
Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:25 PM
Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:28 PM
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:29 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:30 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:31 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:32 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:33 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
4:25 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:59 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
4:25 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form DEF 14A
09/13/2024
5:54 PM
5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:56 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:18 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form PRE 14A
09/04/2024
5:12 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:25 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/27/2024
4:20 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

08/09/2024
4:18 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
4:29 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/05/2024
7:58 AM
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/05/2024
7:59 AM
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
6:05 AM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:27 AM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2024
11:15 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form EFFECT
05/19/2024
11:15 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form EFFECT
04/28/2024
11:15 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form EFFECT
04/24/2024
3:40 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form POS AM
04/10/2024
11:15 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form EFFECT
04/10/2024
3:40 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 424B3
04/10/2024
8:58 AM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form CERT
04/10/2024
6:00 AM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form 8-A12B
04/04/2024
4:32 PM
Skye Bioscience (Filer)
Skye Bioscience (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SKYE) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners